<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02124447</url>
  </required_header>
  <id_info>
    <org_study_id>PRO00022505</org_study_id>
    <nct_id>NCT02124447</nct_id>
  </id_info>
  <brief_title>Single Center Comparison of 4 FDA Approved, Commercially Available Bowel Purgatives for Colonoscopy</brief_title>
  <official_title>Comparison of Efficacy and Patient Tolerability of Four Commercially Available Bowel Purgatives for Screening and Surveillance Colonoscopy: A Single Tertiary Medical Center Experience.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical College of Wisconsin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical College of Wisconsin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a 4-way comparison to prospectively evaluate the efficacy and patient
      tolerability of four commercially available bowel preparations among patients undergoing
      colonoscopy for screening and surveillance in a single tertiary academic medical center.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will randomize 300 consecutive patients undergoing colonoscopy for screening or
      surveillance purposes to receive one of four bowel purgatives. These purgatives include

        1. Split dose 4 liter polyethylene glycol with electrolytes (PEG+E): Brand name GoLytely

        2. Split dose 2 liter polyethylene glycol with ascorbic acid (PEG+Asc): Brand name:
           MoviPrep

        3. Split dose sodium picosulfate, magnesium oxide, and anhydrous citric acid (P+MC): Brand
           name Prepopik

        4. Split dose sodium sulfate, magnesium sulfate, and potassium sulfate solution (sulfate):
           Brand name Suprep
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Protocol issues. Modifications potentially will be undertaken and resubmitted to IRB
  </why_stopped>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of bowel cleansing according to the Boston Bowel Preparation Score (BPPS)</measure>
    <time_frame>Patient outcome will be assessed at the time of the colonoscopy by the performing physician and ducomentation of this outcome will occur within 24 hours of the procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient tolerability and satisfaction</measure>
    <time_frame>Outcome of satisfaction will be assessed on a single survey that the patient will provide the day of their colonoscopy and will be recorded by study personnel up to 30 days thereafter</time_frame>
    <description>Will be assessed using a previously studied satisfaction questionnaire (7 items)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Patients Undergoing Screening or Surveillance Colonoscopy</condition>
  <arm_group>
    <arm_group_label>PEG+E</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Split dose 4 liter polyethylene glycol with electrolytes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PEG+Asc</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Split dose 2 liter polyethylene glycol with ascorbic acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>P+MC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Split dose sodium picosulfate, magnesium oxide, and anhydrous citric acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sulfate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Split dose sodium sulfate, magnesium sulfate, and potassium sulfate solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PEG+E</intervention_name>
    <description>Split dose 4 liter polyethylene glycol with electrolytes</description>
    <arm_group_label>PEG+E</arm_group_label>
    <other_name>Golytely</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PEG+Asc</intervention_name>
    <description>Split dose 2 liter polyethylene glycol with ascorbic acid</description>
    <arm_group_label>PEG+Asc</arm_group_label>
    <other_name>MoviPrep</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>P+MC</intervention_name>
    <description>Split dose sodium picosulfate, magnesium oxide, and anhydrous citric acid</description>
    <arm_group_label>P+MC</arm_group_label>
    <other_name>Suprep</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sulfate</intervention_name>
    <description>Split dose sodium sulfate, magnesium sulfate, and potassium sulfate solution</description>
    <arm_group_label>sulfate</arm_group_label>
    <other_name>Prepopik</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18 years or greater

          2. Ability to understand and complete questionnaires

          3. Ability to speak and read English

          4. Willingness to participate in study

          5. Colonoscopy is being performed for routine screening (i.e. no prior personal history
             of polyps or cancer) or surveillance (i.e. follow up for a personal history of polyps)
             purposes

        Exclusion Criteria:

          1. Previous bowel resection of any kind (small or large bowel)

          2. End stage renal disease (ESRD)

          3. Contraindication to bowel purgative

          4. Necessity for inpatient admission to receive bowel preparation for any reason

          5. Currently taking any narcotic/opiate pain or anticholinergic medication (since these
             may predispose to higher colon stool burden at baseline)

          6. Currently taking stool softeners (e.g. Miralax, Amitiza, Linzess, lactulose) or
             stimulant laxatives (e.g. Dulcolax)

          7. Subject did not follow appropriate dosing instructions for bowel purgative

          8. Colonoscopy is being performed to evaluate a clinical symptom such as rectal bleeding,
             constipation, abdominal pain, or diarrhea

          9. History of colon polyposis syndrome

         10. Personal history of inflammatory bowel disease

         11. History of inadequate colon preparation on any prior colonoscopies

         12. Patient is pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Froedtert Hospital &amp; The Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2014</study_first_submitted>
  <study_first_submitted_qc>April 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2014</study_first_posted>
  <last_update_submitted>July 9, 2015</last_update_submitted>
  <last_update_submitted_qc>July 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical College of Wisconsin</investigator_affiliation>
    <investigator_full_name>Zachary Smith</investigator_full_name>
    <investigator_title>Division of Gastroenterology</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
    <mesh_term>Magnesium Oxide</mesh_term>
    <mesh_term>Sodium sulfate</mesh_term>
    <mesh_term>Cathartics</mesh_term>
    <mesh_term>Citric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

